Viewing Study NCT03412292


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-27 @ 5:18 AM
Study NCT ID: NCT03412292
Status: UNKNOWN
Last Update Posted: 2022-01-19
First Post: 2018-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)
Sponsor: Maxinovel Pty., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module